Published in:
Open Access
01-11-2013 | Meeting abstract
PW03-016 – Blau prospective cohort study: articular outcomes
Authors:
CD Rose, R Cimaz, C Thomee, R Khubchandani, G Espada, R Russo, M Harjacek, B Bader-Meunier, P Brissaud, N Wulffraat, S Vastert, R Merino, A Naranjo-Hernandez, S Oliveira-Knupp, F Mackensen, J Arostegui, J Anton, J Fernandez-Martin, C Wouters
Published in:
Pediatric Rheumatology
|
Special Issue 1/2013
Login to get access
Excerpt
Blau syndrome is an autosomal dominant monogenic granulomatous disease associated with gain of function mutations at or near the NACHT domain of NOD2; it is the only form of granulomatous arthritis with a known gene mutation. Although its phenotype has been amply described as a triad of arthritis, uveitis and dermatitis in case series and retrospective cohorts, prospective studies on natural history and outcome have not been done. …